Everything you need to know about Brazil investing
-
URPR11: Is the Discounted Brazilian Real Estate Fund a Long-Term Buy?
Ticker: URPR11 (Urca Prime Renda FII) Current price: ~R$48.70 Net Asset Value (NAV): R$100.50 Discount to NAV: ~51.5% Distribution Yield (last 12 months): Significantly reduced, recovering slowly Sector: Real estate credit (CRI-backed development projects) 1. What Happened to URPR11? URPR11 was once a high-yield real estate credit fund focused on structured debt for real estate…
-
Petrobras (PETR3, PETR4, PBR): Full 2025 Financial Analysis of Brazil’s Energy Giant
Petrobras (PBR ADR, PETR3, PETR4) is Latin America’s largest energy company and one of the world’s biggest oil producers. The company plays a vital role in Brazil’s economy, not only as a state-controlled enterprise but also as a major global exporter of high-quality crude. Petrobras today operates with world-class upstream assets, growing dividend payouts, and…
-
Brazil’s Central Bank Rate Hike to 15%: What It Means for Investors
Brazil’s Central Bank (Banco Central do Brasil, or BCB) raised the Selic interest rate by 25 basis points to 15% on June 18, 2025. This is now the highest interest rate in Brazil since 2006. The decision, made unanimously by the Monetary Policy Committee (Copom), signals not only the end of the current tightening cycle…
-
Vale (VALE3 / VALE): 2025 Financial Analysis of Brazil’s Mining Titan
Vale S.A. is a leading force in the global mining industry. Known primarily for iron ore, it is expanding its presence in base metals, used in energy transition
-
JHSF (JHSF3) Stock Analysis: High-Yield Exposure to Brazil’s Luxury Ecosystem
JHSF Participações S.A. (B3: JHSF3) is unlike any other real estate company in Brazil. It offers integrated exposure to luxury real estate, high-end shopping centers, boutique hotels and restaurants, and private aviation infrastructure. The company’s long-term strategy to build a vertically integrated lifestyle platform is now translating into record results, recurring cash flows, and a…
-
📈Ibovespa June 11, 2025
📈 Ibovespa at a Glance Top Gainers (Stocks with Best Daily Performance) Top Losers 🔍 Market Commentary & Technical Analysis Mini contracts (WIN, minidollar, mini-BTC): Summary
-
The Brazilian Stock Market in 2024: A Perspective on Politics, Policies, and Global Influences
Introduction As we navigate through 2024, the Brazilian stock market presents a fascinating study of the interplay between domestic politics, global economic trends, and policy reforms. This article delves into how various factors, including the Lula administration, the US elections, changing interest rates, and recent reforms, are shaping the trajectory of Brazil’s financial markets. The…
-
Trump Effect? Experts begin to see the first impacts of the American election on the markets
In his last term, the Republican increased protectionism and generated a trade war with China. Last Tuesday (16th), financial market experts pointed out that the American elections may have had an impact on the market. The overwhelming victory of former President Donald Trump in one of the first Republican Party primaries in Iowa is said…
-
Bank advises increasing exposure to the Brazilian stock market for the first time in three years.
The investment strategy committee of Itaú Unibanco that before suggested maintaining a neutral position in the domestic stock market, now recommends a position above neutral in August. The team recommended maintaining a neutral position in the domestic stock market and advised a position above neutral (+1, on a scale ranging from -3 to +3) in…
-
Lojas Renner (LREN3) is keeping an eye on lower price ranges to adapt to the new reality of Brazilian consumers
The company also mentions aiming for greater accuracy and better inventory management to overcome the challenging macroeconomic situation. Lojas Renner (LREN3) is adapting to the new reality of Brazilians after a period of high inflation and interest rates that eroded part of the population’s income. In an interview with InfoMoney after the second-quarter results of…
Got any recommendations or questions?
